Medizinische Hochschule Hannover
Hannover Medical School (Medizinische Hochschule Hannover, MHH), founded in 1965, belongs to Germany’s top 5 university medical centers. With its interdisciplinary and interactive mission, MHH entertains strong collaborative links to important academic and industrial research organizations in regional, national and international networks, creating a fine balance of basic, translational and clinical research. Our clinical research arena includes the Clinical Research Centre (CRC Hannover), a state-of-the-art trial center dedicated to phase I/II (including first-in-man) studies. For investigator-initiated and industry-sponsored clinical trials, MHH offers full institutional support in biometrics, pharmacovigilance, and Good Clinical Practice (GCP).
The HepNet Study-House is a recognized center for the development of clinical cohorts and investigator-initiated studies (IITs) in the field of hepatitis. It was founded as a project in the BMBF-funded “Kompetenznetz Hepatitis” and is now a project of the German Liver Foundation. The establishment of the HepNet Study House was accompanied by the formation of a horizontal and vertical network as well as structural and core units. Since the foundation of the “Kompetenznetz Hepatitis”, the HepNet Study House has been an established coordination center for international and national multicentre studies and registries. Vertical networking enables large cohorts of patients to be built using a network of practices and hospitals in addition to the university clinics.
Role in TherVacB
Hannover Medical School (MHH), together with the HepNet Study-House of the German Liver Foundation, is responsible for the establishment of a registry for hepatitis B patients which will be characterized in the run-up to the trial in order to establish a cohort of pateints which meets the inclusion criteria of the clinical trial. MHH will also support patient recruitment through social media and in the clinical trial as a study center.
Senior Physician & Assistant Director
He holds a DZIF professorship and is clinical director of the Helmholtz Centre for Infection Research and director of the Center for Individualized Infection Medicine (CIIM). His clinical focus is on the treatment of patients with infectious liver diseases. Prof. Cornberg was the responsible physician of multiple clinical trials and lead PI of the IITs conducted with the HepNet Study-House. He is also medical director of the German Liver Foundation.
Coordinator HepNet Study-House
She is the coordinator of the HepNet Study-House since 2019 and responsible for the development and coordination of several multicenter, international IITs and patient cohorts.